ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership704,232 shares
Latest Disclosed Value $ 5,401,460
Jane Street Group, Llc ownership in 26CA / ImmunityBio, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 704,232 shares of ImmunityBio, Inc. (DE:26CA) valued at $4,619,762 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 14,224,224 shares of ImmunityBio, Inc.. This represents a change in shares of -95.05% during the quarter. The current value of the position is $4,316,942 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (26CA) in the form of stock options. The firm currently holds call options representing 946,200 of underlying shares valued at $7,257,354 USD and put options representing 703,900 of underlying shares valued at $5,398,913 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:26CA / ImmunityBio, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F IMMUNITYBIO COM 45256X103 704,232 -13,519,992 -95.05 5,401 -80.82 0.0007
2026-02-12 2025-12-31 13F IMMUNITYBIO COM 45256X103 14,224,224 1,388,645 10.82 28,164 -10.81 0.0043
2025-11-14 2025-09-30 13F IMMUNITYBIO COM 45256X103 12,835,579 5,117,314 66.30 31,576 54.96 0.0048
2025-08-14 2025-06-30 13F IMMUNITYBIO COM 45256X103 7,718,265 7,588,902 5,866.36 20,376 5,138.05 0.0040
2025-05-19 2025-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 129,363 -122,712 -48.68 389 -39.69 0.0001
2025-05-14 2025-03-31 13F IMMUNITYBIO COM 45256X103 129,363 -122,712 389 0.0001
2025-02-14 2024-12-31 13F IMMUNITYBIO COM 45256X103 252,075 156,466 163.65 645 81.69 0.0001
2024-11-15 2024-09-30 13F IMMUNITYBIO COM 45256X103 95,609 -1,620,450 -94.43 356 -96.73 0.0001
2024-08-15 2024-06-30 13F IMMUNITYBIO COM 45256X103 1,716,059 1,407,921 456.91 10,845 555.68 0.0025
2024-05-16 2024-03-31 13F IMMUNITYBIO COM 45256X103 308,138 -513,505 -62.50 1,655 -59.89 0.0003
2024-02-15 2023-12-31 13F IMMUNITYBIO COM 45256X103 821,643 821,643 4,125 0.0011
2023-11-15 2023-09-30 13F IMMUNITYBIO COM 45256X103 0 -146,732 -100.00 0 -100.00
2023-08-14 2023-06-30 13F IMMUNITYBIO COM 45256X103 146,732 -78,024 -34.71 408 -0.49 0.0001
2023-05-16 2023-03-31 13F IMMUNITYBIO COM 45256X103 224,756 177,896 379.63 409 72.57 0.0002
2023-02-15 2022-12-31 13F IMMUNITYBIO COM 45256X103 46,860 27,986 148.28 238 152.13 0.0001
2022-11-15 2022-09-30 13F IMMUNITYBIO COM 45256X103 18,874 -23,731 -55.70 94 -40.88 0.0000
2022-08-16 2022-06-30 13F IMMUNITYBIO COM 45256X103 42,605 -107,001 -71.52 159 -81.07 0.0001
2022-05-17 2022-03-31 13F IMMUNITYBIO COM 45256X103 149,606 122,403 449.96 840 409.09 0.0003
2022-02-15 2021-12-31 13F IMMUNITYBIO COM 45256X103 27,203 15,145 125.60 165 39.83 0.0001
2021-11-16 2021-09-30 13F IMMUNITYBIO COM 45256X103 12,058 -17,990 -59.87 118 -72.49 0.0000
2021-08-16 2021-06-30 13F IMMUNITYBIO COM 45256X103 30,048 -12,528 -29.43 429 -57.57 0.0002
2021-05-18 2021-03-31 13F IMMUNITYBIO COM 45256X103 42,576 -30,265 -41.55 1,011 4.12 0.0005
2021-02-17 2020-12-31 13F NANTKWEST COM 63016Q102 72,841 35,041 92.70 971 270.61 0.0005
2020-11-17 2020-09-30 13F NANTKWEST COM 63016Q102 37,800 -26,853 -41.53 262 -67.00 0.0002
2020-08-17 2020-06-30 13F NANTKWEST COM 63016Q102 64,653 64,653 794 0.0006
2019-11-14 2019-09-30 13F NANTKWEST COM 63016Q102 0 -89,914 -100.00 0 -100.00
2019-08-15 2019-06-30 13F NANTKWEST COM 63016Q102 89,914 89,914 92 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F IMMUNITYBIO COM Call 946,200 78.39 7,257 591.14 n/a n/a n/a
2026-02-12 2025-12-31 13F IMMUNITYBIO COM Call 530,400 -8.82 1,050 -26.57 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNITYBIO COM Call 581,700 -0.46 1,431 -7.26 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNITYBIO COM Call 584,400 435.66 1,543 370.12 n/a n/a n/a
2025-05-19 2025-03-31 13F/A IMMUNITYBIO COM Call 109,100 46.84 328 72.63 n/a n/a n/a
2025-05-14 2025-03-31 13F IMMUNITYBIO COM Call 109,100 328 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNITYBIO COM Call 74,300 -88.81 190 -92.31 n/a n/a n/a
2024-11-15 2024-09-30 13F IMMUNITYBIO COM Call 664,100 335.19 2,470 156.22 n/a n/a n/a
2024-08-15 2024-06-30 13F IMMUNITYBIO COM Call 152,600 -16.29 964 -1.43 n/a n/a n/a
2024-05-16 2024-03-31 13F IMMUNITYBIO COM Call 182,300 -78.92 979 -77.48 n/a n/a n/a
2024-02-15 2023-12-31 13F IMMUNITYBIO COM Call 865,000 349.35 4,342 1,236.00 n/a n/a n/a
2023-11-15 2023-09-30 13F IMMUNITYBIO COM Call 192,500 -67.52 325 -80.27 n/a n/a n/a
2023-08-14 2023-06-30 13F IMMUNITYBIO COM Call 592,600 1,435.23 1,647 2,252.86 n/a n/a n/a
2023-05-16 2023-03-31 13F IMMUNITYBIO COM Call 38,600 -45.86 70 -80.61 n/a n/a n/a
2023-02-15 2022-12-31 13F IMMUNITYBIO COM Call 71,300 -12.94 361 -11.30 n/a n/a n/a
2022-11-15 2022-09-30 13F IMMUNITYBIO COM Call 81,900 12.81 407 50.74 n/a n/a n/a
2022-08-16 2022-06-30 13F IMMUNITYBIO COM Call 72,600 53.81 270 1.89 n/a n/a n/a
2022-05-17 2022-03-31 13F IMMUNITYBIO COM Call 47,200 -57.09 265 -60.39 n/a n/a n/a
2022-02-15 2021-12-31 13F IMMUNITYBIO COM Call 110,000 22.09 669 -23.80 n/a n/a n/a
2021-11-16 2021-09-30 13F IMMUNITYBIO COM Call 90,100 -1.85 878 -33.03 n/a n/a n/a
2021-08-16 2021-06-30 13F IMMUNITYBIO COM Call 91,800 -41.49 1,311 -64.81 n/a n/a n/a
2021-05-18 2021-03-31 13F IMMUNITYBIO COM Call 156,900 24.72 3,725 122.12 n/a n/a n/a
2021-02-17 2020-12-31 13F NANTKWEST COM Call 125,800 287.08 1,677 645.33 n/a n/a n/a
2020-11-17 2020-09-30 13F NANTKWEST COM Call 32,500 -25.12 225 -57.79 n/a n/a n/a
2020-08-17 2020-06-30 13F NANTKWEST COM Call 43,400 533 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F IMMUNITYBIO COM Put 703,900 378.84 5,399 1,754.98 n/a n/a n/a
2026-02-12 2025-12-31 13F IMMUNITYBIO COM Put 147,000 344.11 291 259.26 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNITYBIO COM Put 33,100 -66.02 81 -68.48 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNITYBIO COM Put 97,400 67.35 257 46.86 n/a n/a n/a
2025-05-19 2025-03-31 13F/A IMMUNITYBIO COM Put 58,200 -51.46 175 -42.81 n/a n/a n/a
2025-05-14 2025-03-31 13F IMMUNITYBIO COM Put 58,200 175 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNITYBIO COM Put 119,900 90.62 307 31.33 n/a n/a n/a
2024-11-15 2024-09-30 13F IMMUNITYBIO COM Put 62,900 -17.13 234 -51.36 n/a n/a n/a
2024-08-15 2024-06-30 13F IMMUNITYBIO COM Put 75,900 -27.58 480 -14.77 n/a n/a n/a
2024-05-16 2024-03-31 13F IMMUNITYBIO COM Put 104,800 559.12 563 611.39 n/a n/a n/a
2024-02-15 2023-12-31 13F IMMUNITYBIO COM Put 15,900 -3.64 80 192.59 n/a n/a n/a
2023-11-15 2023-09-30 13F IMMUNITYBIO COM Put 16,500 -21.80 28 -53.45 n/a n/a n/a
2023-08-14 2023-06-30 13F IMMUNITYBIO COM Put 21,100 5.50 59 61.11 n/a n/a n/a
2023-05-16 2023-03-31 13F IMMUNITYBIO COM Put 20,000 -79.10 36 -92.58 n/a n/a n/a
2023-02-15 2022-12-31 13F IMMUNITYBIO COM Put 95,700 -24.11 485 -22.65 n/a n/a n/a
2022-11-15 2022-09-30 13F IMMUNITYBIO COM Put 126,100 225.00 627 335.42 n/a n/a n/a
2022-08-16 2022-06-30 13F IMMUNITYBIO COM Put 38,800 -58.50 144 -72.57 n/a n/a n/a
2022-05-17 2022-03-31 13F IMMUNITYBIO COM Put 93,500 59.56 525 47.47 n/a n/a n/a
2022-02-15 2021-12-31 13F IMMUNITYBIO COM Put 58,600 57.10 356 -1.93 n/a n/a n/a
2021-11-16 2021-09-30 13F IMMUNITYBIO COM Put 37,300 -46.41 363 -63.48 n/a n/a n/a
2021-08-16 2021-06-30 13F IMMUNITYBIO COM Put 69,600 -62.01 994 -77.14 n/a n/a n/a
2021-05-18 2021-03-31 13F IMMUNITYBIO COM Put 183,200 14.36 4,349 103.70 n/a n/a n/a
2021-02-17 2020-12-31 13F NANTKWEST COM Put 160,200 780.22 2,135 1,594.44 n/a n/a n/a
2020-11-17 2020-09-30 13F NANTKWEST COM Put 18,200 -62.55 126 -78.89 n/a n/a n/a
2020-08-17 2020-06-30 13F NANTKWEST COM Put 48,600 597 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.